Concepedia

Sylvia Kehlenbrink

SK

Statistics

Publications

14

Citations

756

H-Index

13

Active since

2009

Affiliations

Albert Einstein College of Medicine(Current)

Harvard University

Brigham and Women's Hospital

Center for Drug Evaluation and Research

United States Food and Drug Administration

Sylvia Kehlenbrink is an author at Albert Einstein College of Medicine specializing in diabetes mellitus, metabolic regulation, and medicine.

Publications per year

2009–2022

14

Publications

14

Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis

Sanjay Basu, John Yudkin, Sylvia Kehlenbrink et al. · The Lancet Diabetes & Endocrinology · 2018 · 231 citations · Full text

Medicine, Endocrinology, Diabetology +9

Activation of KATP channels suppresses glucose production in humans

Preeti Kishore, Laura Boucai, Kehao Zhang et al. · Journal of Clinical Investigation · 2011 · 107 citations

Medicine, Endocrinology, Pharmacology +16

Reduced Adipose Tissue Macrophage Content Is Associated With Improved Insulin Sensitivity in Thiazolidinedione-Treated Diabetic Humans

Sudha Koppaka, Sylvia Kehlenbrink, Michelle A. Carey et al. · Diabetes · 2013 · 95 citations · Full text

Medicine, Immunology, Pharmacology +17

An Atypical Form of Diabetes Among Individuals With Low BMI

Eric Lontchi‐Yimagou, Riddhi Dasgupta, Shajith Anoop et al. · Diabetes Care · 2022 · 70 citations · Full text

Medicine, Endocrinology, Internal Medicine +14

Adipocyte-Derived Factors Potentiate Nutrient-Induced Production of Plasminogen Activator Inhibitor–1 by Macrophages

Preeti Kishore, Weijie Li, Julia Tonelli et al. · Science Translational Medicine · 2010 · 48 citations

Life Sciences, Biochemistry, Physiology +17

1–5 of 14